Navigation Links
Light shines for potential early cancer diagnosis technique
Date:12/11/2008

A team led by a Northwestern University biomedical engineer has developed a new optical technique that holds promise for minimally invasive screening methods for the early diagnosis of cancer.

The researchers have shown for the first time that nanoscale changes are present in cells extremely early on in carcinogenesis. Their technique, partial-wave spectroscopy (PWS), can detect subtle abnormal changes in human colon cancer cells even when those same cells appear normal using conventional microscopy.

The study is published online by the Proceedings of the National Academy of Sciences.

A simple yet sensitive method, PWS quantifies the statistical properties of cell nanoscale architecture by using the signal generated by light waves striking the cell.

PWS can provide information not only about individual cells, but it also can look inside the cell and see the cell's fundamental "building blocks," such as proteins, nucleosomes and intracellular membranes, and detect changes to this cell nanoarchitecture. Conventional microscopy cannot do this, and other techniques that can (to some degree) are expensive and complex.

"Imagine a cell as a house and the cell's fundamental building blocks as bricks," said Vadim Backman, professor of biomedical engineering at Northwestern's McCormick School of Engineering and Applied Science.

"Our technique can see not only the sizes of the house's bricks but the details of those bricks. And it can show when those bricks are in trouble even when the house looks normal. Conventional microscopy can see the individual houses but not the bricks that make up the house. That's a significant difference," said Backman, who led the research.

Backman and his colleagues studied both human colon cancer cell lines and cells from a colon cancer animal model. In both cases, the PWS technique showed that an increase in the disorder of cells on the nanoscale parallels genetic events in the early stages of carcinogenesis.

"We have to look at cell morphology at the nanoscale," said Backman. "Cells are not just a bag of molecules -- the nanoarchitecture can control many cellular processes and activities."

The team studied three variants of malignant human cells, each exhibiting a different degree of aggressive behavior. (In all three, the malignancy resulted from genetic alteration.)

Using PWS, the researchers were able to distinguish each cell line. They found architectural disorder in all three but of varying degrees; the most aggressively malignant cell line showed the most intracellular disorder. When viewed using microscopy, all three cell lines looked normal, and each was indistinguishable from the others. The same trend was found in the researchers' study of cells from an animal model.

"If the PWS screening technique for colon cancer is validated by appropriate clinical trials, there is the potential for preventing many thousands of cancer deaths each year," said Allen Taflove, professor of electrical engineering and computer science at Northwestern. He collaborated with Backman in conducting computer simulations of how light interacts with the complex structure of a cell and is an author of the paper.

In addition to cancer research, PWS could find use in biomechanics (to study the nanoscale architecture of polymers, materials or tissue), tissue engineering and stem cell research.

"Anywhere you use microscopy you could use PWS and get more information," said Backman. "PWS can work with virtually anything, and it can detect features as small as 20 nanometers."


'/>"/>

Contact: Megan Fellman
fellman@northwestern.edu
847-491-3115
Northwestern University
Source:Eurekalert

Related medicine news :

1. Stanford study highlights cost-effective method of lowering heart disease risks
2. Study shines more light on benefit of vitamin D in fighting cancer
3. Bacteria See the Light
4. Quantum light beams good for fast technology
5. Free will takes flight: how our brains respond to an approaching menace
6. New MRI finding sheds light on multiple sclerosis disease progressio
7. RA Drugs Linked to Slight Skin Cancer Risk
8. QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH
9. REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
10. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
11. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: